Business
Population Approach Group Europe
Population Approach Group Europe.
About this update from Physiomics Plc
[{"type":"text","content":"\n \nRNS Number : 6948G Physiomics PLC 11 June 2013 \n\n \n \nPhysiomics plc\nThe Magdalen Centre\nThe Oxford Science Park\nRobert Robinson Avenue\nOxford\nOX4 4GA\nUK\n \nTel 01865 784980\nFax 08701 671931\n11 June 2013 \nPhysiomics plc\n(\"Physiomics\") or (\"the Company\")\n \nPhysiomics to present on the new R&D development at the Population Approach Group Europe meeting 2013 (\"PAGE\")\n \nPhysiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it is participating in the PAGE Meeting 2013, taking place at the Glasgow Royal Concert Hall, Glasgow, on 11-14 June 2013. Dr Eric Fernandez, Dr Frances Brightman, and Dr Christophe Chassagnole will present on an updated version of drugCARD, on our newly release cardiac toxicity predictive platform and on our emerging Virtual Tumour clinical platform.\n \nDrugCARD, a new database of anti-cancer drugs and therapeutic treatment information, is the result of collaboration between Physiomics and Pharmacometrics. The first poster will show how researchers and clinicians can rapidly access and search pre-clinical and clinical drug regimen data. The database is in its final stages of testing before its release. \n \nIn the second poster we will present how our new cardiac toxicity model predicts the risk of a fatal heart arrhythmia known as Torsade de Pointes, using low cost and relatively easy to obtain lab-based data. Torsade de Pointes has been responsible for numerous market withdrawals in the last two decades.\n \nThe results presented in the third poster show how we have extended the capabilities of our pre-clinical Virtual Tumour™ model to the clinic. In this literature based case study we have been able to qualitatively predict that certain combination schedules already explored in the clinic can lead to very different outcomes depending on the sequence used.\n \n \nTwo of the abstracts (\"drugCARD: a database of anti-cancer treatment regimens and drug combinations\" and \" Virtual Tumour Clinical: Literature example\") will be presented in the Oncology session, whereas the third one (\"Predicting Torsad...